Evidence map›Paper›PMID 33906839›Full record

ArticleBMJ open2021

Influencing factors and their relationships of risk perception and decision-making behaviour of polypharmacy in patients with chronic diseases: a qualitative descriptive study.

Yuxin Liu, Ruoxi Wang, Rui Huang, Yan Cao, Jia Wang, Da Feng

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxin LiuTongji Medical College, School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0002-6243-5005
Ruoxi WangTongji Medical College, School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0002-9695-0582
Rui HuangTongji Medical College, School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China.
Yan CaoTongji Medical College, School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China.
Jia WangTongji Medical College, School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0001-7160-5662
Da FengTongji Medical College, School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China fengda@hust.edu.cn.ORCID 0000-0003-4392-760X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn order to understand the influencing factors of the medication-taking behaviour in patients with chronic diseases, reveal the deep-seated causes underlying the phenomenon of polypharmacy, explore the formation rules of the risk perception of polypharmacy and how risk perception affect the medication decision-making behaviour of patients with chronic diseases.

designA qualitative descriptive design was used. Study data were collected through semi-structured interviews with patients and physicians. We used the grounded theory approach to refine influencing factors, followed by interpretative structural modelling that analysed the interaction between these factors.

settingPatients from two hospitals, two nursing homes and two communities. Physicians from two community hospitals in Wuhan, China.

participantsPatients with chronic diseases with high willingness to cooperate and good communication ability. Physicians with rich experience in the treatment of chronic diseases.

resultsTwenty-nine interviews were conducted (20 patients and 9 physicians). A total of 35 influencing factors of the medication-taking behaviours in patients with chronic diseases were extracted from the interview data, further integrated into 10 integrated influencing factors and ultimately clustered into three aspects: 'medication benefit', 'medication risk' and 'medication strategy'. Medication risk can be divided into four specific dimensions: economic risk, physical risk, psychosocial risk and time risk. 10 integrated influencing factors constituted the interpretative structural model of the medication decision-making behaviours in patients with chronic diseases.

conclusionsThe causes underlying the medication decision-making behaviour of patients with chronic diseases are complex, involving a series of influencing factors such as their risk perception of the medication-taking behaviour. In order to alleviate the adverse effects of polypharmacy on patients' health and medical costs, further safety measures should be proposed to improve the medication-taking behaviour in patients with chronic diseases based on the relationship and internal mechanism of the influencing factors of the medication decision-making behaviour.

Indexed as

PerceptionPolypharmacyChinaChronic DiseaseHumansQualitative Researchdiabetes & endocrinologyhypertensionrisk management

Identifiers

PMID33906839
PMCPMC8088251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.